(Q31876798)

4 July 2017

title

Nosocomial pneumonia: importance of recognition of aetiological agents to define an appropriate initial empirical therapy (English)

1 reference

4 July 2017

1 reference

Costa SF

1

1 reference

4 July 2017

Newbaer M

2

1 reference

4 July 2017

Santos CR

3

1 reference

4 July 2017

Basso M

4

1 reference

4 July 2017

Soares I

5

1 reference

4 July 2017

Levin AS

6

1 reference

4 July 2017

publication date

1 February 2001

1 reference

International Journal of Antimicrobial Agents

4 July 2017

published in

1 reference

4 July 2017

volume

17

1 reference

4 July 2017

issue

2

1 reference

4 July 2017

page(s)

147-150

1 reference

CDC definitions for nosocomial infections, 1988

4 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900316-2

7 January 2021

Specificity of endotracheal aspiration, protected specimen brush, and bronchoalveolar lavage in mechanically ventilated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900316-2

7 January 2021

Role of the microbiology laboratory in the diagnosis of lower respiratory tract infections

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900316-2

7 January 2021

Epidemiology of ventilator-acquired pneumonia based on protected bronchoscopic sampling

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900316-2

7 January 2021

Follow-up protected specimen brushes to assess treatment in nosocomial pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900316-2

7 January 2021

An outbreak of multiresistant Acinetobacter baumanii in a university hospital in São Paulo, Brazil

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900316-2

7 January 2021

Hospital infection with Acinetobacter spp.: an increasing problem

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900316-2

7 January 2021

Risk factors for infection by Acinetobacter baumannii in intubated patients with nosocomial pneumonia.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900316-2

7 January 2021

Treatment and Prevention of Nosocomial Pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900316-2

7 January 2021

Treatment of severe pneumonia in hospitalized patients: results of a multicenter, randomized, double-blind trial comparing intravenous ciprofloxacin with imipenem-cilastatin. The Severe Pneumonia Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900316-2

7 January 2021

Incidence, risk, and prognosis factors of nosocomial pneumonia in mechanically ventilated patients

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900316-2

7 January 2021

Impact of BAL data on the therapy and outcome of ventilator-associated pneumonia

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900316-2

7 January 2021

10.1016/S0924-8579(00)00316-2

Identifiers

DOI

1 reference

4 July 2017

1 reference